Artiva Biotherapeutics (ARTV) Return on Equity: 2024

Historic Return on Equity for Artiva Biotherapeutics (ARTV) over the last 1 years, with Dec 2024 value amounting to -0.32%.

  • Artiva Biotherapeutics' Return on Equity was N/A to -0.32% in Q4 2024 from the same period last year, while for Dec 2024 it was -0.32%, marking a year-over-year change of. This contributed to the annual value of -5.31% for FY2024, which is N/A change from last year.
  • Per Artiva Biotherapeutics' latest filing, its Return on Equity stood at -0.32% for Q4 2024, which was up 97.24% from -11.56% recorded in Q3 2024.
  • In the past 5 years, Artiva Biotherapeutics' Return on Equity registered a high of 0.18% during Q1 2024, and its lowest value of -11.56% during Q3 2024.
  • In the last 1 years, Artiva Biotherapeutics' Return on Equity had a median value of -0.08% in 2024 and averaged -2.88%.